查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1532518

甲狀腺消融設備市場- 按類型（射頻消融、微波消融）、產品（熱、非熱）、應用（甲狀腺癌、甲狀腺結節）、最終用途（醫院、ASC、癌症專科中心） - 全球預測（2024 年） - 2032)

Thyroid Ablation Devices Market - By Type (Radiofrequency Ablation, Microwave Ablation), Product (Thermal, Non-thermal), Application (Thyroid Cancer, Thyroid Nodules), End-use (Hospitals, ASCs, Cancer Specialty Centers) - Global Forecast (2024 - 2032)
出版日期: | 出版商: Global Market Insights Inc. | 英文 99 Pages | 商品交期: 2-3個工作天內

價格
簡介目錄

由於領先公司獲得 FDA 許可的數量不斷增加，2024 年至 2032 年間，全球甲狀腺消融設備市場的複合年成長率將達到 9.9%。甲狀腺消融是一種用於治療甲狀腺結節和癌症的微創手術，與傳統手術相比，因其有效性和縮短的恢復時間而受到廣泛關注。 FDA 的批准標誌著高水準的安全性和有效性，增強了醫療保健提供者和患者的信心。隨著領先公司獲得更多批准，他們可以將先進的創新設備推向市場，進一步推動採用。

例如，2023 年 11 月，Baird Medical 的微波消融系統獲得 FDA 批准，該系統是專為切除甲狀腺結節而設計的裝置。該公司執行長預計這項創新技術在美國的潛在市場規模將達到 16 億美元。

甲狀腺疾病的盛行率不斷增加，加上對侵入性較小的治療方案的渴望，正在推動甲狀腺消融設備市場的成長。科技的進步和人們對消融手術益處的認知不斷提高，導致需求不斷成長。這一趨勢反映了甲狀腺疾病管理中向先進、以患者為中心的解決方案的更廣泛轉變。

甲狀腺消融設備產業的整體價值根據類型、產品、應用、最終用戶和地區進行分類。

根據類型，微波消融領域的甲狀腺消融設備市場收入從2024 年到2032 年將實現令人稱讚的複合年成長率。 。該技術利用微波能量精確瞄準並破壞異常組織，從而縮短恢復時間並減少併發症。微波消融的好處，包括其有效性和較低的風險狀況，已導致醫療保健提供者和患者擴大採用微波消融。隨著人們對這些優勢的認知不斷增強以及技術不斷進步，甲狀腺消融設備（尤其是利用微波技術的設備）的市場正在顯著擴大。

就產品而言，從 2024 年到 2032 年，基於非熱的設備領域將出現顯著成長。這些方法提供精確且受控的消融，降低併發症的風險並改善患者的治療效果。隨著醫療保健專業人員和患者尋求具有更好安全性的侵入性較小的選擇，非熱基設備越來越受歡迎。它們以最小的不適和更快的恢復時間有效地靶向甲狀腺結節，正在推動市場成長並擴大甲狀腺消融領域的治療選擇。

歐洲甲狀腺消融設備市場從2024 年到2032 年將呈現顯著的複合年成長率。縮短恢復時間並降低風險。甲狀腺疾病的日益流行和向以患者為中心的護理的轉變正在推動這一趨勢。此外，歐洲監管部門的批准和創新療法的醫療保健資金進一步推動了市場成長。隨著歐洲的醫療保健提供者和患者尋求高效、侵入性較小的治療方法，甲狀腺消融設備市場正在該地區迅速擴張。

目錄

第 1 章：方法與範圍

第 2 章：執行摘要

第 3 章：產業洞察

  • 產業生態系統分析
  • 產業影響力
    • 成長動力
      • 甲狀腺癌和甲狀腺結節盛行率上升
      • 微創手術日益受到青睞
      • 消融設備的技術進步
      • 提高認知和篩檢計劃
    • 產業陷阱與挑戰
      • 甲狀腺消融設備成本高
      • 缺乏熟練的專業人員
  • 成長潛力分析
  • 技術景觀
  • 監管環境
  • 波特的分析
  • PESTEL分析

第 4 章：競爭格局

  • 介紹
  • 公司市佔率分析
  • 競爭定位矩陣
  • 戰略展望矩陣

第 5 章：市場估計與預測：按類型，2021 - 2032

  • 主要趨勢
  • 射頻消融術
  • 微波消融
  • 其他類型

第 6 章：市場估計與預測：按產品分類，2021 - 2032 年

  • 主要趨勢
  • 基於熱的設備
  • 非熱基設備

第 7 章：市場估計與預測：按應用分類，2021 - 2032

  • 主要趨勢
  • 甲狀腺癌
  • 甲狀腺結節

第 8 章：市場估計與預測：按最終用途，2021 - 2032 年

  • 主要趨勢
  • 醫院
  • 門診手術中心
  • 癌症專科中心
  • 其他最終用戶

第 9 章：市場估計與預測：按地區，2021 - 2032

  • 主要趨勢
  • 北美洲
    • 美國
    • 加拿大
  • 歐洲
    • 德國
    • 英國
    • 法國
    • 西班牙
    • 義大利
    • 荷蘭
    • 歐洲其他地區
  • 亞太地區
    • 中國
    • 日本
    • 印度
    • 澳洲
    • 韓國
    • 亞太地區其他地區
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 阿根廷
    • 拉丁美洲其他地區
  • 中東和非洲
    • 南非
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 中東和非洲其他地區

第 10 章：公司簡介

  • AngioDynamics, Inc.
  • Boston Scientific Corporation
  • BVM Medical Limited
  • Integra Lifesciences Holdings Corporation
  • Johnson & Johnson
  • Medtronic plc
  • MedWaves, Inc.
  • Olympus Corporation
  • STARmed Co., Ltd.
  • Stryker Corporation
  • Terumo Corporation
  • Theraclion SA
簡介目錄
Product Code: 9576

Global Thyroid Ablation Devices Market will witness a 9.9% CAGR between 2024 and 2032 due to the increasing number of FDA clearances granted to leading companies. Thyroid ablation, a minimally invasive procedure used to treat thyroid nodules and cancer, has gained significant attention for its effectiveness and reduced recovery times compared to traditional surgery. FDA clearances signal a high level of safety and efficacy, boosting confidence among healthcare providers and patients. As leading companies receive more approvals, they can bring advanced and innovative devices to market, further driving adoption.

For instance, in November 2023, Baird Medical received FDA clearance for its microwave ablation system, a device designed for the removal of thyroid nodules. The company's CEO anticipated a potential market size of $1.6 billion in the U.S. for this innovative technology.

The increasing prevalence of thyroid disorders, coupled with the desire for less invasive treatment options, is fueling the growth of the thyroid ablation devices market. Enhanced technology and growing awareness about the benefits of ablation procedures contribute to rising demand. This trend reflects a broader shift towards advanced, patient-centric solutions in the management of thyroid conditions.

The overall Thyroid Ablation Devices Industry value is classified based on the type, product, application, end-user, and region.

Based on type, the thyroid ablation devices market revenue from the microwave ablation segment will register a commendable CAGR from 2024 to 2032. Microwave ablation offers a minimally invasive alternative to traditional surgical methods for treating thyroid nodules and tumors. This technique uses microwave energy to precisely target and destroy abnormal tissue, resulting in reduced recovery times and fewer complications. The benefits of microwave ablation, including its effectiveness and lower risk profile, have led to growing adoption among healthcare providers and patients. As awareness of these advantages spreads and technology improves, the market for thyroid ablation devices, particularly those utilizing microwave technology, is expanding significantly.

In terms of product, the nonthermal-based devices segment will witness an appreciable growth from 2024 to 2032. Non-thermal techniques, such as radiofrequency ablation and cryoablation, offer alternative methods that minimize heat damage to surrounding tissues. These methods provide precise and controlled ablation, reducing the risk of complications and improving patient outcomes. As healthcare professionals and patients seek less invasive options with better safety profiles, non-thermal-based devices are gaining popularity. Their effectiveness in targeting thyroid nodules with minimal discomfort and faster recovery times is driving market growth and expanding treatment options in the thyroid ablation sector.

Europe thyroid ablation devices market will exhibit a notable CAGR from 2024 to 2032. European healthcare systems are prioritizing advanced technologies that offer effective solutions for managing thyroid conditions with reduced recovery times and lower risks compared to traditional surgery. The growing prevalence of thyroid disorders and a shift towards patient-centric care are driving this trend. Additionally, European regulatory approvals and healthcare funding for innovative treatments further boost market growth. As healthcare providers and patients in Europe seek efficient, less invasive therapies, the thyroid ablation devices market is expanding rapidly in the region.

Table of Contents

Chapter 1 Methodology & Scope

  • 1.1 Market scope & definitions
  • 1.2 Research design
    • 1.2.1 Research approach
    • 1.2.2 Data collection methods
  • 1.3 Base estimates & calculations
    • 1.3.1 Base year calculation
    • 1.3.2 Key trends for market estimation
  • 1.4 Forecast model
  • 1.5 Primary research and validation
    • 1.5.1 Primary sources
    • 1.5.2 Data mining sources

Chapter 2 Executive Summary

  • 2.1 Industry 360° synopsis

Chapter 3 Industry Insights

  • 3.1 Industry ecosystem analysis
  • 3.2 Industry impact forces
    • 3.2.1 Growth drivers
      • 3.2.1.1 Rising prevalence of thyroid cancer & thyroid nodules
      • 3.2.1.2 Growing preference for minimally invasive surgeries
      • 3.2.1.3 Technological advancements in ablation devices
      • 3.2.1.4 Increasing awareness and screening programs
    • 3.2.2 Industry pitfalls & challenges
      • 3.2.2.1 High cost of thyroid ablation devices
      • 3.2.2.2 Lack of skilled professionals
  • 3.3 Growth potential analysis
  • 3.4 Technological landscape
  • 3.5 Regulatory landscape
  • 3.6 Porter's analysis
  • 3.7 PESTEL analysis

Chapter 4 Competitive Landscape, 2023

  • 4.1 Introduction
  • 4.2 Company market share analysis
  • 4.3 Competitive positioning matrix
  • 4.4 Strategy outlook matrix

Chapter 5 Market Estimates and Forecast, By Type, 2021 - 2032 ($ Mn)

  • 5.1 Key trends
  • 5.2 Radiofrequency ablation
  • 5.3 Microwave ablation
  • 5.4 Other types

Chapter 6 Market Estimates and Forecast, By Product, 2021 - 2032 ($ Mn)

  • 6.1 Key trends
  • 6.2 Thermal based devices
  • 6.3 Non-thermal based devices

Chapter 7 Market Estimates and Forecast, By Application, 2021 - 2032 ($ Mn)

  • 7.1 Key trends
  • 7.2 Thyroid cancer
  • 7.3 Thyroid nodules

Chapter 8 Market Estimates and Forecast, By End-use, 2021 - 2032 ($ Mn)

  • 8.1 Key trends
  • 8.2 Hospitals
  • 8.3 Ambulatory surgical centers
  • 8.4 Cancer specialty centers
  • 8.5 Other end-users

Chapter 9 Market Estimates and Forecast, By Region, 2021 - 2032 ($ Mn)

  • 9.1 Key trends
  • 9.2 North America
    • 9.2.1 U.S.
    • 9.2.2 Canada
  • 9.3 Europe
    • 9.3.1 Germany
    • 9.3.2 UK
    • 9.3.3 France
    • 9.3.4 Spain
    • 9.3.5 Italy
    • 9.3.6 Netherlands
    • 9.3.7 Rest of Europe
  • 9.4 Asia Pacific
    • 9.4.1 China
    • 9.4.2 Japan
    • 9.4.3 India
    • 9.4.4 Australia
    • 9.4.5 South Korea
    • 9.4.6 Rest of Asia Pacific
  • 9.5 Latin America
    • 9.5.1 Brazil
    • 9.5.2 Mexico
    • 9.5.3 Argentina
    • 9.5.4 Rest of Latin America
  • 9.6 Middle East and Africa
    • 9.6.1 South Africa
    • 9.6.2 Saudi Arabia
    • 9.6.3 UAE
    • 9.6.4 Rest of Middle East and Africa

Chapter 10 Company Profiles

  • 10.1 AngioDynamics, Inc.
  • 10.2 Boston Scientific Corporation
  • 10.3 BVM Medical Limited
  • 10.4 Integra Lifesciences Holdings Corporation
  • 10.5 Johnson & Johnson
  • 10.6 Medtronic plc
  • 10.7 MedWaves, Inc.
  • 10.8 Olympus Corporation
  • 10.9 STARmed Co., Ltd.
  • 10.10 Stryker Corporation
  • 10.11 Terumo Corporation
  • 10.12 Theraclion SA